The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma

SIMPLE SUMMARY: Due to the malignant features of glioma, current interventions result in limited treatment effects and poor prognoses for all patients. The functions of the tropomyosin (TPM) family in tumors and cancers have been explored. However, striking differences have been observed. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ke, Wang, Huihui, Xu, Jia, Xu, Ruiming, Liu, Zelin, Li, Yi, Xu, Zhaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332389/
https://www.ncbi.nlm.nih.gov/pubmed/35892971
http://dx.doi.org/10.3390/biology11081115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332389/
https://www.ncbi.nlm.nih.gov/pubmed/35892971
http://dx.doi.org/10.3390/biology11081115

Ejemplares similares